- LIC IPO: At Rs 5.54 lakh cr market cap on BSE, state-run insurer becomes 5th largest company on debut
- Dalal Street Corner: Metals, broader markets help bulls take control; what should investors do on Wednesday?
- What makes LIC shares good dividend, long-term play? Experts decode
- SC extends demolition deadline of Supertech’s twin towers till 28 August
- Apple AirPods, MagSafe chargers likely to come with USB Type-C port - Check details
COVID-19
Economy Returning to Normalcy: Jefferies highlights Covid-19 Recovery in India
Wed, Jan 06, 2021
Covid-19: Jefferies recovery tracker was 99%+ for December, exiting at a 100% rate, indicating that the economy is normalising fast. Sustenance of recovery post the festive season is reassuring. Urban indicators for travel & realty have seen good improvement. Record GST collections align with several broad indicators' strength. No COVID second-wave so far has been a relief. Jefferies maintain their pro-recovery stance on banks, property, materials & industrials.
More >
COVID-19 Vaccine Rollout: From healthcare workers, frontline workers, elderly to general public, who gets it first
Tue, Jan 05, 2021
Morgan Stanley Highlights that Indian government's first goal in its upcoming vaccination drive is to protect lives by safeguarding the vulnerable population. Thereafter, it aims to stop transmission of the virus. For vaccine logistics, the government has established 31 main hubs from where vaccines will be distributed to 29000 vaccination points with the help of state governments. The government has identified 51k public health facilities and 162k private health facilities for vaccine rollout.
More >
From Bharat Biotech Covaxin, AstraZeneca/Oxford/ Serum Institute' Covishield and much more: EXPLAINED
Mon, Jan 04, 2021
Bharat Biotech's Covaxin is an exception as it is still in Phase-3 and yet to complete trial recruitment. No interim analysis of efficacy is available and pre-print Phase-1/2 data have only given details on immunogenicity and not efficacy of the vaccine. The emergency use approval, even as a back-up vaccine, is therefore highly unusual. Government authorities have announced that Serum's Covishield will remain the primary vaccine for the time being and Bharat Biotech's Covaxin will be in back-up, only to be used in case of a surge in case.
More >
COVID-19 shook, rattled and rolled the global economy in 2020
Thu, Dec 31, 2020
When 2020 dawned, the global economy had just notched its 10th straight year of uninterrupted growth, a streak most economists and government finance officials expected to persist for years ahead in a 21st Century version of the "Roaring `20s."
More >
Night curfew in Delhi dates: Due to fear of Covid-19 spread and threat by new UK strain, govt announces clampdown
Thu, Dec 31, 2020
Night curfew in Delhi dates: The Delhi government has imposed night curfew from 11 pm to 6 am on December 31 and January 1 to avoid large gatherings during New Year celebrations due to COVID-19 and its highly transmissible UK strain.
More >
New Covid-19 strain in India: 6 UK returnees' samples carry mutant coronavirus variant
Tue, Dec 29, 2020
New Covid-19 strain in India: The samples of six UK returnees in Bengaluru, Hyderabad and Pune have been found to be positive with the new variant genome, the central government said on Tuesday, adding that they have been kept in a single-room-isolation in designated healthcare facilities.
More >
Explained - New Covid-19 strain in South Africa: Is the fear justified? Revealed in just 4 points
Fri, Dec 25, 2020
Explained - New Covid-19 strain in South Africa: South Africa has identified a new variant of the novel coronavirus, which authorities believe is driving a surge in COVID-19 infections that could overwhelm its healthcare system.
More >
Pfizer COVID-19 vaccine: More than 600,000 people in UK get first dose
Fri, Dec 25, 2020
Pfizer COVID-19 vaccine: More than 600,000 people in the United Kingdom have received the first dose of the Pfizer-BioNTech COVID-19 vaccine since inoculations began in the country earlier this month, the British government said on Thursday.
More >
AstraZeneca says its Covid-19 vaccine should be effective against new coronavirus variant
Wed, Dec 23, 2020
British drugmaker AstraZeneca Plc told Reuters on Tuesday its COVID-19 vaccine should be effective against the new coronavirus variant, adding that studies were under way to fully probe the impact of the mutation.
More >
